| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |